Comparison

DLK2 Antibody (C-term) Blocking Peptide

Item no. ABC-BP9025b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Mural R.J., et.al., Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Protein delta homolog 2,DLK-2,Epidermal growth factor-like protein 9,EGF-like protein 9,DLK2,EGFL9
Similar products DLK2, EGFL9, Protein delta homolog 2, Epidermal growth factor-like protein 9, DLK-2, EGF-like protein 9
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence used to generate the antibody AP9025b was selected from the C-term region of human DLK2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background
DLK2 (Delta like protein 2) affects adipogenesis of 3T3-L1 preadipocytes and mesenchymal C3H10T1/2 cells suggesting a role as a regulator of adipogenesis.
Gene Name
DLK2
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close